Product: Idarubicin Hydrochloride Injection 20 mg/20 mL, 20 mL single-dose vial, Rx only, Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0703-4156-11
Reason for recall: Lack of Assurance of Sterility
Recall initiated: 20210729
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated